Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 28, 2018; 24(40): 4586-4595
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4586
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4586
Table 2 Second primary malignancy of different treatment groups
| All patients | Surgery-only | Long | Short | Post | |
| All SPM | 1270 (100) | 1056 (100) | 49 (100) | 10 (100) | 155 (100) |
| Head and neck | 89 (7) | 69 (6.5) | 7 (14.3) | 2 (20) | 11 (7.1) |
| Esophagus | 31 (2.4) | 28 (2.7) | 0 (0) | 0 (0) | 3 (1.9) |
| Stomach | 82 (6.5) | 68 (6.4) | 4 (8.2) | 1 (10) | 9 (5.8) |
| Liver | 183 (14.4) | 162 (15.3) | 3 (6.1) | 3 (30) | 15 (9.7) |
| Pancreas | 31 (2.4) | 26 (2.5) | 1 (2) | 0 (0) | 4 (2.6) |
| Lung | 284 (22.4) | 224 (21.2) | 16 (32.7) | 0 (0) | 44 (28.4) |
| Bone | 17 (1.3) | 14 (1.3) | 0 (0) | 0 (0) | 3 (1.9) |
| Skin | 31 (2.4) | 23 (2.2) | 1 (2) | 2 (20) | 5 (3.2) |
| Breast | 82 (6.5) | 71 (6.7) | 3 (6.1) | 0 (0) | 8 (5.2) |
| Cervix | 18 (1.4) | 17 (1.6) | 0 (0) | 0 (0) | 1 (0.6) |
| Uterus | 15 (1.2) | 10 (0.9) | 2 (4.1) | 0 (0) | 3 (1.9) |
| Ovary | 10 (0.8) | 10 (0.9) | 0 (0) | 0 (0) | 0 (0) |
| Prostate | 129 (10.2) | 116 (11) | 2 (4.1) | 1 (10) | 10 (6.5) |
| Bladder | 83 (6.5) | 63 (6) | 2 (4.1) | 0 (0) | 18 (11.6) |
| Kidney | 45 (3.5) | 40 (3.8) | 1 (2) | 1 (10) | 3 (1.9) |
| Thyroid | 18 (1.4) | 15 (1.4) | 0 (0) | 0 (0) | 3 (1.9) |
| Hematologic | 59 (4.6) | 46 (4.4) | 3 (6.1) | 0 (0) | 10 (6.5) |
| Others | 63 (5) | 54 (5.1) | 4 (8.2) | 0 (0) | 5 (3.2) |
- Citation: Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Second primary malignancy risk after radiotherapy in rectal cancer survivors. World J Gastroenterol 2018; 24(40): 4586-4595
- URL: https://www.wjgnet.com/1007-9327/full/v24/i40/4586.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i40.4586